Harry J.F. Bloomfield - Net Worth and Insider Trading
Harry J.F. Bloomfield Net Worth
The estimated net worth of Harry J.F. Bloomfield is at least $480 dollars as of 2024-11-13. Harry J.F. Bloomfield is the Director of Algernon Pharmaceuticals Inc and owns about 6,000 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) stock worth over $480. Details can be seen in Harry J.F. Bloomfield's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Harry J.F. Bloomfield has not made any transactions after 2022-04-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Harry J.F. Bloomfield
Harry J.F. Bloomfield Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Harry J.F. Bloomfield owns 1 companies in total, including Algernon Pharmaceuticals Inc (XCNQ:AGN) .
Click here to see the complete history of Harry J.F. Bloomfield’s form 4 insider trades.
Insider Ownership Summary of Harry J.F. Bloomfield
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
XCNQ:AGN | Algernon Pharmaceuticals Inc | 2022-04-12 | Director |
Harry J.F. Bloomfield Latest Holdings Summary
Harry J.F. Bloomfield currently owns a total of 1 stock. Harry J.F. Bloomfield owns 6,000 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) as of April 12, 2022, with a value of $480.
Latest Holdings of Harry J.F. Bloomfield
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
XCNQ:AGN | Algernon Pharmaceuticals Inc | 2022-04-12 | 6,000 | 0.08 | 480 |
Holding Weightings of Harry J.F. Bloomfield
Harry J.F. Bloomfield Form 4 Trading Tracker
According to the SEC Form 4 filings, Harry J.F. Bloomfield has made a total of 6 transactions in Algernon Pharmaceuticals Inc (XCNQ:AGN) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Algernon Pharmaceuticals Inc is the acquisition of 600 shares on April 12, 2022, which cost Harry J.F. Bloomfield around $3,630.
Insider Trading History of Harry J.F. Bloomfield
- 1
Harry J.F. Bloomfield Trading Performance
GuruFocus tracks the stock performance after each of Harry J.F. Bloomfield's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Harry J.F. Bloomfield is -21.63%. GuruFocus also compares Harry J.F. Bloomfield's trading performance to market benchmark return within the same time period. The performance of stocks bought by Harry J.F. Bloomfield within 3 months outperforms 2 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Harry J.F. Bloomfield's insider trading performs compared to the benchmark.
Performance of Harry J.F. Bloomfield
Harry J.F. Bloomfield Ownership Network
Ownership Network List of Harry J.F. Bloomfield
Ownership Network Relation of Harry J.F. Bloomfield
Harry J.F. Bloomfield Owned Company Details
What does Algernon Pharmaceuticals Inc do?
Who are the key executives at Algernon Pharmaceuticals Inc?
Harry J.F. Bloomfield is the Director of Algernon Pharmaceuticals Inc. Other key executives at Algernon Pharmaceuticals Inc include Director & Senior Officer Christopher Moreau , Senior Officer Christopher Scott Bryan , and Senior Officer James Kinley .
Algernon Pharmaceuticals Inc (XCNQ:AGN) Insider Trades Summary
Over the past 18 months, Harry J.F. Bloomfield made no insider transaction in Algernon Pharmaceuticals Inc (XCNQ:AGN). Other recent insider transactions involving Algernon Pharmaceuticals Inc (XCNQ:AGN) include a net purchase of 62,500 shares made by Christopher Moreau , a net purchase of 60,500 shares made by Christopher Scott Bryan , and a net purchase of 12,500 shares made by James Kinley .
In summary, during the past 3 months, insiders sold 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 0 shares of Algernon Pharmaceuticals Inc (XCNQ:AGN) were sold and 135,500 shares were bought by its insiders, resulting in a net purchase of 135,500 shares.
Algernon Pharmaceuticals Inc (XCNQ:AGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Algernon Pharmaceuticals Inc Insider Transactions
Harry J.F. Bloomfield Mailing Address
Above is the net worth, insider trading, and ownership report for Harry J.F. Bloomfield. Currently GuruFocus does not have mailing address information for Harry J.F. Bloomfield.